Spironolactone in end stage renal disease: A story of under'ACHIEVE'ment. [PDF]
Mathew GG.
europepmc +1 more source
[Costs of pharmacological treatment in hypertension and type 2 diabetes mellitus]. [PDF]
Figueroa-García J +5 more
europepmc +1 more source
[Performance of prognostic scores during the first and second waves of COVID-19 pneumonia] [PDF]
Reyna SMT +18 more
europepmc +1 more source
Demonstration of sizing nursing staff methods in intensive care. [PDF]
Batassini É, Oliveira JLC, Beghetto MG.
europepmc +1 more source
[Need, Opportunity, and Accessibility: Application of the NOA method to analyze the effectiveness of the organ transplant system in BrazilNecesidad, oportunidad y accesibilidad: aplicación del método NOA para analizar la eficacia del sistema de trasplante de órganos en Brasil]. [PDF]
Thomé T +7 more
europepmc +1 more source
Prevention is less expensive than treatment in chronic kidney disease: a descriptive analysis. [PDF]
Alcalde PR, Fernandes DE, Kirsztajn GM.
europepmc +1 more source
[Hyperuricaemia as a cardiovascular risk factor]. [PDF]
Álvarez Lozano B +3 more
europepmc +1 more source
Evaluación del diseño y costo-efectividad de un modelo de pruebas en el lugar de atención para mejorar la capacidad de resolución de las urgencias hospitalarias. [PDF]
Jimenez-Barragan M +2 more
europepmc +1 more source
Association between Renal Function and the Incidence of Major Adverse Cardiovascular Outcomes 1 Year After the First Acute Myocardial Infarction. [PDF]
Moreira DM +5 more
europepmc +1 more source
Papel del laboratorio clínico en el estudio de nefrolitiasis y cristaluria por mesalazina. [PDF]
Balbuena AI +3 more
europepmc +1 more source

